Variant report
Variant | esv3490106 |
---|---|
Chromosome Location | chr8:63033798-63041596 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs571635152 | chr8:63033804-63033805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs191483559 | chr8:63033814-63033815 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs11779597 | chr8:63033830-63033831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs566698159 | chr8:63033834-63033835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs533978858 | chr8:63033848-63033849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs576193370 | chr8:63033871-63033872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs573504210 | chr8:63033883-63033884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs543872207 | chr8:63033892-63033893 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs182512730 | chr8:63033901-63033902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs149773103 | chr8:63033904-63033905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs144703278 | chr8:63033947-63033948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs374725730 | chr8:63034006-63034007 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs367815792 | chr8:63034007-63034008 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs543311914 | chr8:63034033-63034034 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs72666306 | chr8:63034041-63034042 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs555976679 | chr8:63034047-63034048 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs572356220 | chr8:63034050-63034051 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs72666307 | chr8:63034055-63034056 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs140600085 | chr8:63034063-63034064 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs375875281 | chr8:63034072-63034073 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs144552187 | chr8:63034106-63034107 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs532549703 | chr8:63034119-63034120 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564322955 | chr8:63034136-63034137 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs147818323 | chr8:63034252-63034253 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs566074302 | chr8:63034281-63034282 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs141353750 | chr8:63034299-63034300 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs549280680 | chr8:63034302-63034303 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs72666308 | chr8:63034308-63034309 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs537681009 | chr8:63034328-63034329 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs142543818 | chr8:63034338-63034339 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs149021061 | chr8:63034369-63034370 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs577359989 | chr8:63034401-63034402 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs543920306 | chr8:63034428-63034429 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs150959398 | chr8:63034432-63034433 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs140655405 | chr8:63034445-63034446 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs563489931 | chr8:63034466-63034467 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs114411667 | chr8:63034467-63034468 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs542918318 | chr8:63034488-63034489 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs374146760 | chr8:63034489-63034490 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs561603551 | chr8:63034506-63034507 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs72666309 | chr8:63034517-63034518 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs75054363 | chr8:63034520-63034521 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs187151820 | chr8:63034574-63034575 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs548717655 | chr8:63034578-63034579 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs72666310 | chr8:63034596-63034597 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs528372680 | chr8:63034599-63034600 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs547872218 | chr8:63034618-63034619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs367635764 | chr8:63034653-63034654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs551384801 | chr8:63034694-63034695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs73268915 | chr8:63034704-63034705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Colorectal cancer | 21645411 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:63032400-63034000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
2 | chr8:63032400-63034600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr8:63033600-63034200 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
4 | chr8:63033600-63034200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr8:63033800-63034200 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
6 | chr8:63034000-63038200 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
7 | chr8:63034200-63036200 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
8 | chr8:63034600-63037400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr8:63037200-63039600 | Enhancers | Brain Germinal Matrix | brain |
10 | chr8:63037400-63038000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr8:63038200-63038600 | Enhancers | Cortex derived primary cultured neurospheres | brain |
12 | chr8:63039200-63039400 | Enhancers | Aorta | Aorta |
13 | chr8:63040000-63041400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr8:63040600-63041400 | Bivalent Enhancer | iPS-18 Cell Line | embryonic stem cell |
15 | chr8:63040800-63041400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
16 | chr8:63040800-63041400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
17 | chr8:63041000-63041400 | Bivalent Enhancer | iPS-15b Cell Line | embryonic stem cell |